Insider · CIK 0001902629

Gruis Kirsten L

Reports to the SEC for 1 company · MINNEAPOLIS, MN

Transactions

Companies

Filings

CIK

0001902629

Forms 4 and 5

Insider transactions

2 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2023-06-01	DMACDiaMedica Therapeutics Inc. · Stock Option (right to buy)A Award	Chief Medical Officer	AAward	+67K sh	—	—	67,000
2022-01-03	DMACDiaMedica Therapeutics Inc. · Stock Option (right to buy)A Award	Chief Medical Officer	AAward	+160K sh	—	—	160,000

TWO CARLSON PARKWAY, SUITE 260

MINNEAPOLIS, MN, 55447